...
首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >Consumer product in vitro digestion model: Bioaccessibility of contaminants and its application in risk assessment.
【24h】

Consumer product in vitro digestion model: Bioaccessibility of contaminants and its application in risk assessment.

机译:消费品体外消化模型:污染物的生物可及性及其在风险评估中的应用。

获取原文
获取原文并翻译 | 示例
           

摘要

This paper describes the applicability of in vitro digestion models as a tool for consumer products in (ad hoc) risk assessment. In current risk assessment, oral bioavailability from a specific product is considered to be equal to bioavailability found in toxicity studies in which contaminants are usually ingested via liquids or food matrices. To become bioavailable, contaminants must first be released from the product during the digestion process (i.e. become bioaccessible). Contaminants in consumer products may be less bioaccessible than contaminants in liquid or food. Therefore, the actual risk after oral exposure could be overestimated. This paper describes the applicability of a simple, reliable, fast and relatively inexpensive in vitro method for determining the bioaccessibility of a contaminant from a consumer product. Different models, representing sucking and/or swallowing were developed. The experimental design of each model can be adjusted to the appropriate exposure scenarios as determined by the risk assessor. Several contaminated consumer products were tested in the various models. Although relevant in vivo data are scare, we succeeded to preliminary validate the model for one case. This case showed good correlation and never underestimated the bioavailability. However, validation check needs to be continued.
机译:本文描述了体外消化模型作为消费产品在(临时)风险评估中的工具的适用性。在当前的风险评估中,特定产品的口服生物利用度被认为与毒性研究中发现的生物利用度相等,在毒性研究中,污染物通常是通过液体或食品基质摄入的。为了变得可生物利用,必须在消化过程中首先从产品中释放污染物(即变得可生物利用)。消费品中的污染物可能比液体或食品中的污染物难于获取。因此,口服接触后的实际风险可能被高估。本文介绍了一种简单,可靠,快速且相对便宜的体外方法,用于确定消费品中污染物的生物可及性。开发了代表吸吮和/或吞咽的不同模型。可以将每个模型的实验设计调整为风险评估者确定的适当暴露场景。在各种模型中测试了几种受污染的消费品。尽管相关的体内数据令人恐惧,但我们成功地为一个案例初步验证了该模型。该病例显示出良好的相关性,从未低估过生物利用度。但是,验证检查需要继续。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号